In asthma, airway inflammation can be suppressed by peroxisome proliferator‐activated receptor‐alpha (PPAR‐α) agonists as it reduces the release of inflammatory mediators majorly involved in asthma (Gholijani et al., 2016; Rolim et al., 2019; Sun et al., 2020). The gene discussed is PPARA; the disease is asthma.